JOSHUA BROAD: Open Payments
NPI 1134382013 · RIDGECREST, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 21 payments from 10 companies in 2025. Trend: 2023 $135 · 2024 $305 · 2025 $458
Food & beverage: $329Education: $129
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $147 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $50 |
| Amgen Inc. | 1 | $34 |
| LEO Pharma Inc. | 2 | $29 |
| Cycle Pharmaceuticals Inc | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: DUPIXENT, NEFFY, Rhapsido, ADBRY, Sajazir, TAKHZYRO, ALVESCO, EBGLYSS.
Industry payments across CA — which companies pay providers there.
